Home » Healthcare » Pharmaceuticals » Therapeutic Monoclonal Antibodies Market

Therapeutic Monoclonal Antibodies Market By Type of Thyroid Disorder (Hypothyroidism, Hyperthyroidism, Thyroid Nodules, Thyroiditis, Thyroid Cancer); By Treatment Modality (Medications, Surgical Interventions, Radiotherapy, Others); By Diagnostic Tests (Thyroid Function Tests, Thyroid Ultrasound, Fine Needle Aspiration Biopsy, Thyroid Scan, Molecular Testing, Others); By End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Cancer Treatment Centers, Others); By Region – Trends, Analysis, and Forecast, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Therapeutic Monoclonal Antibodies Market Size 2023	USD 2451.2 Million
Therapeutic Monoclonal Antibodies Market, CAGR	3.50%
Therapeutic Monoclonal Antibodies Market Size 2032	USD 3340.7 Million

Market Insights

The global demand for Therapeutic Monoclonal Antibodies was valued at USD 2451.2 Million in 2023 and is expected to reach USD 3340.7 Million in 2032, growing at a CAGR of 3.50% between 2024 and 2032.
In 2023, the Hypothyroidism category dominated the global Thyroid Gland Disorder Treatment market, with Hyperthyroidism predicted to grow at the quickest CAGR.
In 2023, pharmaceuticals will dominate the global market for thyroid gland disorders, with surgical treatments serving as an alternative treatment.
Thyroid Function Tests are likely the most significant share, while the fastest-growing field could be Molecular Testing.
Hospitals provide a majority of thyroid gland disease treatments, and diagnostic labs are rapidly expanding.
In 2023, North America had the biggest revenue share at 46%, and the Asia Pacific region is forecast to have the quickest growth rate of 12.1% throughout the projected period.
The rising prevalence of thyroid disorders promotes market expansion.
Limited access to healthcare services impedes market expansion.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

Thyroid diseases can cause raised or decreased amounts of metabolic hormones, resulting in hypothyroidism and hyperthyroidism. Iodine shortage and autoimmune illness can both induce thyroid disorders. Iodine deficiency is a key risk factor for developing thyroid disorders. Technological advancements in thyroid problem therapy are also expected to drive market expansion during the forecast period. Radioactive iodine (I-131) is used to treat hyperthyroidism. It is an effective way of treatment. It is now more commonly used as a first-line treatment instead of surgery, which reduces thyroxin levels and gland size.

Market Overview

The global Thyroid Gland Disorders Treatment Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 3.50% between 2024 and 2032. The market was valued at USD 2451.2 million in 2023 and is expected to reach USD 3340.7 million in 2032.

Thyroid cancer is a big issue that is increasing the need for treatment. To meet demand, many medications are in the pipeline, but only a few have gotten approval. In May 2018, the FDA approved a combination of two targeted medications, dabrafenib and trametinib, to treat patients with anaplastic thyroid cancer. The combination of Tafinlar (dabrafenib) and Mekinist (trametinib) is the first FDA-approved treatment for this kind of thyroid cancer. Furthermore, the FDA authorized Lenvatinib in 2015 for the treatment of locally recurrent or metastatic differentiated thyroid carcinoma that is progressing and resistant to radioactive iodine. In the same year, Japan got approval for the manufacturing and marketing of Lenvima, an anticancer medication used to treat thyroid cancer.

The thyroid disease therapy market size is also predicted to expand significantly throughout the forecast period, owing to the rising prevalence of thyroid cancer. For instance, the National Cancer Institute of the United States reported in 2016 that there were an estimated 822,242 persons living with thyroid cancer in the United States. Furthermore, the American Cancer Society expects that thyroid cancer in the United States will result in approximately 52,070 new cases (14,260 in men and 37,810 in women) and approximately 2,170 deaths (1,020 in men and 1,150 in women) in 2019.

The high cost of thyroid disorder therapy may limit its expansion over the forecast period. For example, according to the National Center for Biotechnology Information’s 2015 report, the total national cost of well-differentiated thyroid cancer (WDTC) care in 2013 was $1.6 billion.

Segmentation By Type of Thyroid Disorder

In 2023, the Hypothyroidism segment dominated the worldwide Thyroid Gland Disorder Treatment market. Hypothyroidism is among the most common thyroid illnesses worldwide. It happens when the thyroid gland fails to generate adequate thyroid hormones, resulting in a variety of symptoms such as fatigue, weight gain, and depression.
Hyperthyroidism is expected to develop at the fastest CAGR of 11.6% throughout the projected timeframe. This part focuses on treatments for excessive thyroid function.

Segmentation By Treatment Modality

In terms of value, the Medications category will lead the global market for thyroid gland disorders in 2023. The medication section discusses the use of synthetic thyroid hormones like levothyroxine for hypothyroidism and antithyroid pharmaceuticals like methimazole and propylthiouracil for hyperthyroidism.
Surgical interventions are another treatment option for thyroid gland disorders. The thyroid gland can be surgically removed, either partially or fully. When other therapies have failed or there is thyroid cancer present, this medication is commonly used.

Segmentation by Diagnostic Tests

Thyroid Function Tests, which involve evaluating levels of hormones such as TSH, T3, and T4, are likely the most significant share ownership sector. This region is critical for detecting and monitoring thyroid problems.
However, the fastest-growing area could be Molecular Testing, such as genetic testing for thyroid cancer. Molecular testing provides individualized and targeted therapy choices, which is driving its rapid market expansion as precision medicine becomes more important in controlling thyroid problems.

Segmentation By End-User

Hospitals account for the majority of the thyroid gland disease treatment market. These outlets are popular for one basic reason. This is because it is capable of managing a wide range of thyroid problems. Hospitals and clinics can provide long-term and short-term treatments, as well as diagnostics and consultations.
Although hospitals and clinics dominate the industry, diagnostic labs are experiencing rapid development. The understanding and awareness of thyroid disorders has grown, emphasizing the significance of a precise and timely diagnosis.

Segmentation by Region

In 2023, North America had the greatest revenue share at 46%.
The Asia Pacific area is expected to have the fastest growth rate of 12.1% over the projection period.
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Therapeutic Monoclonal Antibodies.

North America emerged as the dominating player in the worldwide Thyroid Gland Disorder Treatment market in 2023, accounting for the highest market share in terms of value. North America, notably the United States and Canada, has a sophisticated healthcare infrastructure, including well-established diagnostic and treatment facilities for thyroid diseases. Both healthcare professionals and the general public widely understand thyroid problems. The region has a large number of patients with thyroid problems, such as hypothyroidism and thyroid cancer. North America is a hotbed of pharmaceutical innovation, with numerous major corporations researching and marketing thyroid problem medicines.

Moreover, The Asia-Pacific market is expected to be the fastest-growing, providing lucrative potential prospects for Thyroid Gland Disorder Treatment manufacturers over the forecast period. Countries in the Asia-Pacific area, such as China and India, are increasing their healthcare expenditures, resulting in better access to healthcare services and pharmaceuticals. Thyroid diseases are becoming more widely known throughout Asia-Pacific, prompting an increase in the number of people seeking treatment.

Also, Changing urban lives and nutritional choices have contributed to a rise in thyroid problems. Pharmaceutical companies are aggressively targeting the Asia-Pacific market, providing new medications to meet the rising need for thyroid problem therapies.

Key Highlights of the Report

Type of Thyroid Disorder, Treatment Modality, Diagnostic Tests, End-User, and region segment of the global Thyroid Gland Disorders Treatment Market. In 2023, Fully Human Monoclonal Antibodies held the largest market share, with oncology dominating. Furthermore, Intravenous (IV) Administration is the most prevalent segment, followed by Human Epidermal Growth Factor Receptor 2 (HER2) Inhibitors. Furthermore, Humanized Monoclonal Antibodies have the quickest CAGR. and North America, leading the market growth.

The incidence of thyroid problems, advances in diagnostic technology, and greater awareness and screening programs are the primary driving forces behind the industry. Furthermore, key market restraints include restricted treatment options, pharmacological side effects, and expensive treatment prices. Furthermore, increased healthcare expenditure, strategic alliances and collaborations, and the expanding need for generic drugs are the major potential in the business.

North America emerged as the dominant participant in the global Thyroid Gland Disorder Treatment market in 2023, with the largest market share in terms of value. North America, particularly the United States and Canada, has a sophisticated healthcare infrastructure that includes established testing and treatment facilities for thyroid problems. Furthermore, the Asia-Pacific market is predicted to be the fastest-growing, presenting significant opportunities for Thyroid Gland Disorder Treatment manufacturers over the research period.

What Are The Main Drivers Of The Global Thyroid Gland Disorders Treatment Market?

The increasing frequency of thyroid problems is driving the Thyroid Gland problems Treatment Market, creating a greater demand for appropriate treatment alternatives. Technological breakthroughs in the field are transforming treatment methods, resulting in more accurate and tailored medicines for patients. Furthermore, rising awareness campaigns and activities concentrating on early diagnosis are moving the market forward by encouraging rapid intervention and management of thyroid disorders.

What Are The Major Challenges Faced By The Global Thyroid Gland Disorders Treatment Market?

On the other hand, the market confronts constraints such as the potential negative effects of certain medications, which may discourage some patients from seeking specific remedies. Furthermore, high treatment costs might be a barrier to access for people seeking care for thyroid problems. In some locations, limited healthcare facilities and resources make it difficult to provide effective care to all persons in need.

What Are The Growth Opportunities In The Global Thyroid Gland Disorders Treatment Market?

Despite these obstacles, the Thyroid Gland Disorders Treatment Market offers exciting prospects for growth and development. Ongoing research and development activities in the field are paving the way for innovative medicines that have the potential to transform the therapeutic landscape for thyroid disorders. The rise of personalized medical techniques tailored to specific patients’ demands creates a tremendous possibility for more effective and targeted treatment strategies.

Market Drivers

Several factors drive the global Thyroid Gland Disorders Treatment Market. The following are the key drivers of the global Thyroid Gland Disorders Treatment Market:

Increased Prevalence of Thyroid Disorders

The increasing prevalence of thyroid problems is a primary driver of market expansion. These disorders, including hypothyroidism, hyperthyroidism, and thyroid cancer, are growing more widespread around the world. Several variables contribute to this pattern. Modern lives are associated with an increased incidence of thyroid diseases due to stress, sedentary behavior, and poor nutritional choices.

Environmental variables, including radiation and pollutants, have been linked to thyroid malfunction. The older population is especially vulnerable to thyroid diseases, and the number of instances is predicted to increase as the world’s population ages. Increased awareness and routine screening initiatives have resulted in more people being diagnosed with thyroid diseases, driving up demand for treatment choices.

Market Restraints

The global Thyroid Gland Disorders Treatment Market faces some challenges that may hinder its growth. These include the following:

Limited Access to Healthcare Services

The Global Thyroid Gland Disorder Treatment Market faces significant challenges due to limited healthcare access, particularly in underprivileged regions and rising nations. Many people in these areas lack access to high-quality healthcare and the diagnostic tools needed for early detection and treatment of thyroid diseases. Due of restricted access to healthcare, thyroid diseases are diagnosed and treated later. As a result, patients may have worsening health conditions, higher healthcare bills, and a lower overall quality of life. The lack of access further impedes market expansion by limiting the number of patients seeking thyroid disease therapies. Addressing this issue necessitates expenditures in healthcare infrastructure, professional training, and the implementation of outreach initiatives to reach remote and underprivileged people. Telemedicine and mobile health units can also play an important role in bringing healthcare to remote communities.

Opportunities

The global Thyroid Gland Disorders Treatment Market offers significant growth opportunities. These include the following:

Personalized Medicine and Targeted Therapy

One of the most important developments in the Global Thyroid Gland Disorder Treatment Market is the shift to personalized medicine and focused therapy. Healthcare practitioners are increasingly using a patient-centric approach, adapting therapies to the unique characteristics of each patient. This includes genetic profiling and molecular analysis to detect specific mutations or indicators linked to thyroid diseases.

Personalized medicine enables more accurate and effective treatment strategies, lowering the likelihood of adverse effects while enhancing patient outcomes. Targeted medicines, such as tyrosine kinase inhibitors for advanced thyroid cancer, are gaining popularity because of their potential to block specific biochemical pathways implicated in disease progression. This tendency benefits market growth because it promotes innovation in the creation of precise medications and diagnostics. Pharmaceutical companies are investing in R&D to develop medications that directly address the underlying causes of thyroid problems. As a result, the industry is experiencing an increase in innovative and sophisticated treatment choices.

Competitive Landscape

Key Players

The global Thyroid Gland Disorders Treatment Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Abbvie Inc.
Amgen Inc.
GSK Plc
Merck KGaA
Viatris Inc.
Novartis AG
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Elexis Inc.
IBSA Pharma (IBSA Group)

These organizations prioritize product innovation, Diagnostic Tests expansion, and mergers and acquisitions to stay competitive.

The global Thyroid Gland Disorders Treatment Market’s key players continually seek to stay ahead by offering new products and developments.

In May 2023, Prolevi Bio announced the development of a technology aimed at assisting 10 to 20% of patients with underactive thyroid glands who do not react to current treatments.

May 2022, The United States Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide) injection, Eli Lilly and Company’s new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

In September, 2023, AbbVie and Allergan Aesthetics report positive topline results from the second phase 3 study of OnabotulinumtoxinA (BOTOX® Cosmetic) for treating Platysma Prominence.

In September 2023, Amgen reported positive results from a Phase 3 study of AMG 785 in patients with early-stage non-small cell lung cancer (NSCLC) after surgery.

Summary of Key Findings

Personalized medicine and targeted therapies
The market is segmented by Type of Thyroid Disorder, Treatment Modality, Diagnostic Tests, End-User, and region.
Hyperthyroidism is predicted to grow at the quickest CAGR.
In 2023, medications will dominate the global market for thyroid gland disorders
North America is leading in market growth; the market is highly competitive, with key players including Abbvie Inc., Amgen Inc., GSK Plc, Merck KGaA and Others.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Future Outlook

Increased prevalence of thyroid diseases
Technological advances in therapy options.
Raising awareness and promoting early detection initiatives
Rising healthcare spending and infrastructure development.

How CXOs Can Benefit from the Credence Research Thyroid Gland Disorders Treatment Market Report

The Credence Research Thyroid Gland Disorders Treatment Market Report provides CXOs with a comprehensive overview of the market, including:

Market size and growth forecast: The report provides detailed estimates of the global Thyroid Gland Disorders Treatment Market size, segmented By Type of Thyroid Disorder, Treatment Modality, Diagnostic Tests, End-User and region. It also includes forecasts for the market through 2032 based on key trends and drivers.
Market segmentation: The report segments the Thyroid Gland Disorders Treatment Market By Type of Thyroid Disorder, Treatment Modality, Diagnostic Tests, End-User and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
Competitive Landscape: The report profiles the key players in the Thyroid Gland Disorders Treatment Market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the Thyroid Gland Disorders Treatment Market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Thyroid Gland Disorders Treatment Market Report to:

Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the Thyroid Gland Disorders Treatment Market. For example, by analyzing the data and trends in the report, they can make informed decisions on where to invest and expand their business.
Make informed investment decisions: The report can help CXOs make informed investment decisions about Therapeutic Monoclonal Antibodies. For example, it may provide useful insights into market trends, customer preferences, the competitive landscape, and growth prospects in the mobile accessories business..
Develop competitive strategies: The report can help CXOs develop competitive strategies for their Therapeutic Monoclonal Antibodies businesses. For example, by analyzing market trends, client preferences, and the competitive environment mentioned in the report, CXOs can fine-tune their strategies, differentiate their offers, and effectively position their firms in the marketplace.
Track market developments: The report can help CXOs monitor market developments and stay ahead of the curve. For example, it provides insights into the latest trends and innovations in the Thyroid Gland Disorders Treatment Market.

Overall, the Credence Research Thyroid Gland Disorders Treatment Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify .opportunities for growth.

Segmentation

By Type of Thyroid Disorder:
- Hypothyroidism
- Hyperthyroidism
- Thyroid Nodules
- Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis)
- Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma)
By Treatment Modality:
- Medications:
- Thyroid Hormone Replacement Therapy (e.g., levothyroxine for hypothyroidism)
- Antithyroid Drugs (e.g., methimazole, propylthiouracil for hyperthyroidism)
- Radioactive Iodine Therapy
- Chemotherapy and Targeted Therapy (for thyroid cancer)
- Surgical Interventions:
- Thyroidectomy (partial or total removal of the thyroid gland)
- Radiofrequency Ablation (RFA) for Thyroid Nodules
- Radiotherapy (external beam radiation therapy for thyroid cancer)
- Others
By Diagnostic Tests:
- Thyroid Function Tests (e.g., TSH, T3, T4 levels)
- Thyroid Ultrasound
- Fine Needle Aspiration Biopsy (FNAB)
- Thyroid Scan (e.g., radioactive iodine scan)
- Molecular Testing (e.g., genetic testing for thyroid cancer)
- Others
By End-User:
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Cancer Treatment Centers
- Others
By Region
- North America
  - The U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - The U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Thyroid Gland Disorders Treatment Market
2.1.1. Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder
2.1.2. Global Thyroid Gland Disorders Treatment Market, By Treatment Modality
2.1.3. Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests
2.1.4. Global Thyroid Gland Disorders Treatment Market, By End-User
2.1.5. Global Thyroid Gland Disorders Treatment Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Thyroid Gland Disorders Treatment Market Value, 2019-2032, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Thyroid Gland Disorders Treatment Market Drivers
3.2.2. Thyroid Gland Disorders Treatment Market Restraints
3.2.3. Thyroid Gland Disorders Treatment Market Opportunities
3.2.4. Major Thyroid Gland Disorders Treatment Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Thyroid Disorder
3.5.2. Treatment Modality
3.5.3. Diagnostic Tests
3.5.4. End-User
3.5.5. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2023
4.1.1. Global Thyroid Gland Disorders Treatment Market: Company Market Share, Value 2023
4.1.2. Global Thyroid Gland Disorders Treatment Market: Top 6 Company Market Share, Value 2023
4.1.3. Global Thyroid Gland Disorders Treatment Market: Top 3 Company Market Share, Value 2023
4.2. Global Thyroid Gland Disorders Treatment Market: Company Revenue Share Analysis, 2023
4.3. Company Assessment Metrics, 2023
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2023
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type of Thyroid Disorder Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type of Thyroid Disorder Matrix
4.7. Potential for New Players in the Global Thyroid Gland Disorders Treatment Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. End-User Analysis
5.6.1. Thyroid Ultrasound in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2023
6.1. Company market share of key players, 2023
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type of Thyroid Disorder Launch
6.5.5. Geographical Expansion
6.5.6. Surgical Interventions
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Thyroid Gland Disorders Treatment Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type of Thyroid Disorder Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder
8.1. Global Thyroid Gland Disorders Treatment Market Overview, By Type of Thyroid Disorder
8.1.1. Global Thyroid Gland Disorders Treatment Market Revenue Share, By Type of Thyroid Disorder, 2023 Vs 2032 (in %)
8.2. Hypothyroidism
8.2.1. Global Thyroid Gland Disorders Treatment Market, By HYPOTHYROIDISM, By Region, 2019-2032 (US$ Mn)
8.2.2. Market Dynamics for HYPOTHYROIDISM
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Hyperthyroidism
8.3.1. Global Thyroid Gland Disorders Treatment Market, By HYPERTHYROIDISM, By Region, 2019-2032 (US$ Mn)
8.3.2. Market Dynamics for HYPERTHYROIDISM
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Thyroid Nodules
8.4.1. Global Thyroid Gland Disorders Treatment Market, By Thyroid Nodules, By Region, 2019-2032 (US$ Mn)
8.4.2. Market Dynamics for Thyroid Nodules
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis)
8.5.1. Global Thyroid Gland Disorders Treatment Market, By Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis), By Region, 2019-2032 (US$ Mn)
8.5.2. Market Dynamics for Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis)
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma)
8.6.1. Global Thyroid Gland Disorders Treatment Market, By Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma), By Region, 2019-2032 (US$ Mn)
8.6.2. Market Dynamics for Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma)
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
9. Global Thyroid Gland Disorders Treatment Market, By Treatment Modality
9.1. Global Thyroid Gland Disorders Treatment Market Overview, By Treatment Modality
9.1.1. Global Thyroid Gland Disorders Treatment Market Revenue Share, By Treatment Modality, 2023 Vs 2032 (in %)
9.2. Medications
9.2.1. Global Thyroid Gland Disorders Treatment Market, By Medications, By Region, 2019-2032 (US$ Mn)
9.2.2. Market Dynamics for Medications
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Surgical Interventions
9.3.1. Global Thyroid Gland Disorders Treatment Market, By Surgical Interventions, By Region, 2019-2032 (US$ Mn)
9.3.2. Market Dynamics for Surgical Interventions
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests
10.1. Global Thyroid Gland Disorders Treatment Market Overview, By Diagnostic Tests
10.1.1. Global Thyroid Gland Disorders Treatment Market Revenue Share, By Diagnostic Tests, 2023 Vs 2032 (in %)
10.2. Thyroid Function Tests (e.g., TSH, T3, T4 levels)
10.2.1. Global Thyroid Gland Disorders Treatment Market, By Thyroid Function Tests (e.g., TSH, T3, T4 levels), By Region, 2019-2032 (US$ Mn)
10.2.2. Market Dynamics for Thyroid Function Tests (e.g., TSH, T3, T4 levels)
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Thyroid Ultrasound
10.3.1. Global Thyroid Gland Disorders Treatment Market, By Thyroid Ultrasound, By Region, 2019-2032 (US$ Mn)
10.3.2. Market Dynamics for Thyroid Ultrasound
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Fine Needle Aspiration Biopsy (FNAB)
10.4.1. Global Thyroid Gland Disorders Treatment Market, By Fine Needle Aspiration Biopsy (FNAB), By Region, 2019-2032 (US$ Mn)
10.4.2. Market Dynamics for Fine Needle Aspiration Biopsy (FNAB)
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Thyroid Scan (e.g., radioactive iodine scan)
10.5.1. Global Thyroid Gland Disorders Treatment Market, By Thyroid Scan (e.g., radioactive iodine scan), By Region, 2019-2032 (US$ Mn)
10.5.2. Market Dynamics for Thyroid Scan (e.g., radioactive iodine scan)
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Molecular Testing (e.g., genetic testing for thyroid cancer)
10.6.1. Global Thyroid Gland Disorders Treatment Market, By Molecular Testing (e.g., genetic testing for thyroid cancer), By Region, 2019-2032 (US$ Mn)
10.6.2. Market Dynamics for Molecular Testing (e.g., genetic testing for thyroid cancer)
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends
10.7. Others
10.7.1. Global Thyroid Gland Disorders Treatment Market, By Others, By Region, 2019-2032 (US$ Mn)
10.7.2. Market Dynamics for Others
10.7.2.1. Drivers
10.7.2.2. Restraints
10.7.2.3. Opportunities
10.7.2.4. Trends
11. Global Thyroid Gland Disorders Treatment Market, By End-User
11.1. Global Thyroid Gland Disorders Treatment Market Overview, by End-User
11.1.1. Global Thyroid Gland Disorders Treatment Market Revenue Share, By End-User, 2023 Vs 2032 (in %)
11.2. Hospitals
11.2.1. Global Thyroid Gland Disorders Treatment Market, By Hospitals, By Region, 2019-2032 (US$ Mn)
11.2.2. Market Dynamics for Hospitals
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Specialty Clinics
11.3.1. Global Thyroid Gland Disorders Treatment Market, By Specialty Clinics, By Region, 2019-2032 (US$ Mn)
11.3.2. Market Dynamics for Specialty Clinics
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Diagnostic Laboratories
11.4.1. Global Thyroid Gland Disorders Treatment Market, By Diagnostic Laboratories, By Region, 2019-2032 (US$ Mn)
11.4.2. Market Dynamics for Diagnostic Laboratories
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Ambulatory Surgical Centers
11.5.1. Global Thyroid Gland Disorders Treatment Market, By Ambulatory Surgical Centers, By Region, 2019-2032 (US$ Mn)
11.5.2. Market Dynamics for Ambulatory Surgical Centers
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
11.6. Cancer Treatment Centers
11.6.1. Global Thyroid Gland Disorders Treatment Market, By Cancer Treatment Centers, By Region, 2019-2032 (US$ Mn)
11.6.2. Market Dynamics for Cancer Treatment Centers
11.6.2.1. Drivers
11.6.2.2. Restraints
11.6.2.3. Opportunities
11.6.2.4. Trends
11.7. Others
11.7.1. Global Thyroid Gland Disorders Treatment Market, By Others, By Region, 2019-2032 (US$ Mn)
11.7.2. Market Dynamics for Others
11.7.2.1. Drivers
11.7.2.2. Restraints
11.7.2.3. Opportunities
11.7.2.4. Trends
12. Global Thyroid Gland Disorders Treatment Market, By Region
12.1. Global Thyroid Gland Disorders Treatment Market Overview, by Region
12.1.1. Global Thyroid Gland Disorders Treatment Market, By Region, 2023 vs 2032 (in%)
12.2. Type of Thyroid Disorder
12.2.1. Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032 (US$ Mn)
12.3. Treatment Modality
12.3.1. Global Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032 (US$ Mn)
12.4. Diagnostic Tests
12.4.1. Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032 (US$ Mn)
12.5. End-User
12.5.1. Global Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032 (US$ Mn)
13. North America Thyroid Gland Disorders Treatment Market Analysis
13.1. Overview
13.1.1. Market Dynamics for North America
13.1.1.1. Drivers
13.1.1.2. Restraints
13.1.1.3. Opportunities
13.1.1.4. Trends
13.2. North America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. North America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. North America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. North America Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
13.5.1. Overview
13.5.2. SRC Analysis
13.6. North America Thyroid Gland Disorders Treatment Market, by Country, 2019-2032(US$ Mn)
13.6.1. North America Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
13.6.2. U.S.
13.6.3. Canada
13.6.4. Mexico
14. Europe Thyroid Gland Disorders Treatment Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. Europe Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Europe Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Europe Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Europe Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. Europe Thyroid Gland Disorders Treatment Market, by Country, 2019-2032 (US$ Mn)
14.6.1. Europe Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
14.6.2. UK
14.6.3. France
14.6.4. Germany
14.6.5. Italy
14.6.6. Spain
14.6.7. Benelux
14.6.8. Russia
14.6.9. Rest of Europe
15. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Asia Pacific Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Asia Pacific Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Asia Pacific Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Asia Pacific Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Asia Pacific Thyroid Gland Disorders Treatment Market, by Country, 2019-2032 (US$ Mn)
15.6.1. Asia Pacific Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
15.6.2. China
15.6.3. Japan
15.6.4. India
15.6.5. South Korea
15.6.6. South East Asia
15.6.7. Rest of Asia Pacific
16. Latin America Thyroid Gland Disorders Treatment Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Latin America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Latin America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Latin America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Latin America Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Latin America Thyroid Gland Disorders Treatment Market, by Country, 2019-2032 (US$ Mn)
16.6.1. Latin America Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
16.6.2. Brazil
16.6.3. Argentina
16.6.4. Rest of Latin America
17. Middle East Thyroid Gland Disorders Treatment Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Middle East Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Middle East Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Middle East Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Middle East Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Middle East Thyroid Gland Disorders Treatment Market, by Country, 2019-2032 (US$ Mn)
17.6.1. Middle East Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
17.6.2. UAE
17.6.3. Saudi Arabia
17.6.4. Rest of Middle East
18. Africa Thyroid Gland Disorders Treatment Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2032(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2032(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2032(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Africa Thyroid Gland Disorders Treatment Market, By End-User, 2019-2032(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Africa Thyroid Gland Disorders Treatment Market, by Country, 2019-2032 (US$ Mn)
18.6.1. Middle East Thyroid Gland Disorders Treatment Market, by Country, 2023 Vs 2032 (in%)
18.6.2. South Africa
18.6.3. Egypt
18.6.4. Rest of Africa
19. Company Profiles
19.1. Abbvie Inc.
19.1.1. Company Overview
19.1.2. Type of Thyroid Disorders/Services Portfolio
19.1.3. Geographical Presence
19.1.4. SWOT Analysis
19.1.5. Financial Summary
19.1.5.1. Market Revenue and Net Profit (2019-2023)
19.1.5.2. Business Segment Revenue Analysis
19.1.5.3. Geographical Revenue Analysis
19.2. Amgen Inc.
19.3. GSK Plc
19.4. Merck KGaA
19.5. Viatris Inc.
19.6. Novartis AG
19.7. Pfizer Inc.
19.8. Takeda Pharmaceutical Company Limited
19.9. Elexis Inc.
19.10. IBSA Pharma (IBSA Group)
20. Research Methodology
20.1. Research Methodology
20.2. Thyroid Function Tests (e.g., TSH, T3, T4 levels) – Secondary Research
20.3. Thyroid Function Tests (e.g., TSH, T3, T4 levels)I – Data Modelling
20.3.1. Company Share Analysis Model
20.3.2. Revenue Based Modelling
20.4. Thyroid Function Tests (e.g., TSH, T3, T4 levels)II – Primary Research
20.5. Research Limitations
20.5.1. Assumptions

List of Figures
FIG. 1 Global Thyroid Gland Disorders Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Thyroid Gland Disorders Treatment Market Segmentation
FIG. 4 Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023 (US$ Mn)
FIG. 5 Global Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023 (US$ Mn)
FIG. 6 Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023 (US$ Mn)
FIG. 7 Global Thyroid Gland Disorders Treatment Market, by End-User, 2023 (US$ Mn)
FIG. 8 Global Thyroid Gland Disorders Treatment Market, by Geography, 2023 (US$ Mn)
FIG. 9 Attractive Investment Proposition, By Type of Thyroid Disorder, 2023
FIG. 10 Attractive Investment Proposition, By Treatment Modality, 2023
FIG. 11 Attractive Investment Proposition, By Diagnostic Tests, 2023
FIG. 12 Attractive Investment Proposition, By End-User, 2023
FIG. 13 Attractive Investment Proposition, by Geography, 2023
FIG. 14 Global Market Share Analysis of Key Thyroid Gland Disorders Treatment Market Manufacturers, 2023
FIG. 15 Global Market Positioning of Key Thyroid Gland Disorders Treatment Market Manufacturers, 2023
FIG. 16 Global Thyroid Gland Disorders Treatment Market Value Contribution, By Type of Thyroid Disorder, 2023 & 2032 (Value %)
FIG. 17 Global Thyroid Gland Disorders Treatment Market, by Hypothyroidism, Value, 2019-2032 (US$ Mn)
FIG. 18 Global Thyroid Gland Disorders Treatment Market, by Hyperthyroidism, Value, 2019-2032 (US$ Mn)
FIG. 19 Global Thyroid Gland Disorders Treatment Market, by Thyroid Nodules, Value, 2019-2032 (US$ Mn)
FIG. 20 Global Thyroid Gland Disorders Treatment Market, by Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis), Value, 2019-2032 (US$ Mn)
FIG. 21 Global Thyroid Gland Disorders Treatment Market, by Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma), Value, 2019-2032 (US$ Mn)
FIG. 22 Global Thyroid Gland Disorders Treatment Market Value Contribution, By Treatment Modality, 2023 & 2032 (Value %)
FIG. 23 Global Thyroid Gland Disorders Treatment Market, by Medications, Value, 2019-2032 (US$ Mn)
FIG. 24 Global Thyroid Gland Disorders Treatment Market, by Surgical Interventions, Value, 2019-2032 (US$ Mn)
FIG. 25 Global Thyroid Gland Disorders Treatment Market Value Contribution, By Diagnostic Tests, 2023 & 2032 (Value %)
FIG. 26 Global Thyroid Gland Disorders Treatment Market, by Thyroid Function Tests (e.g., TSH, T3, T4 levels), Value, 2019-2032 (US$ Mn)
FIG. 27 Global Thyroid Gland Disorders Treatment Market, by Thyroid Ultrasound, Value, 2019-2032 (US$ Mn)
FIG. 28 Global Thyroid Gland Disorders Treatment Market, by Fine Needle Aspiration Biopsy (FNAB), Value, 2019-2032 (US$ Mn)
FIG. 29 Global Thyroid Gland Disorders Treatment Market, by Thyroid Scan (e.g., radioactive iodine scan), Value, 2019-2032 (US$ Mn)
FIG. 30 Global Thyroid Gland Disorders Treatment Market, by Molecular Testing (e.g., genetic testing for thyroid cancer), Value, 2019-2032 (US$ Mn)
FIG. 31 Global Thyroid Gland Disorders Treatment Market, by Others, Value, 2019-2032 (US$ Mn)
FIG. 32 Global Thyroid Gland Disorders Treatment Market Value Contribution, By End-User, 2023 & 2032 (Value %)
FIG. 33 Global Thyroid Gland Disorders Treatment Market, by Hospitals, Value, 2019-2032 (US$ Mn)
FIG. 34 Global Thyroid Gland Disorders Treatment Market, by Specialty Clinics, Value, 2019-2032 (US$ Mn)
FIG. 35 Global Thyroid Gland Disorders Treatment Market, by Diagnostic Laboratories, Value, 2019-2032 (US$ Mn)
FIG. 36 Global Thyroid Gland Disorders Treatment Market, by Ambulatory Surgical Centers, Value, 2019-2032 (US$ Mn)
FIG. 37 Global Thyroid Gland Disorders Treatment Market, by Cancer Treatment Centers, Value, 2019-2032 (US$ Mn)
FIG. 38 Global Thyroid Gland Disorders Treatment Market, by Others, Value, 2019-2032 (US$ Mn)
FIG. 39 North America Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 40 U.S. Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 41 Canada Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 42 Mexico Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 43 Europe Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 44 Germany Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 45 France Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 46 U.K. Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 47 Italy Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 48 Spain Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 49 Benelux Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 50 Russia Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 51 Rest of Europe Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 52 Asia Pacific Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 53 China Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 54 Japan Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 55 India Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 56 South Korea Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 57 South-East Asia Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 58 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 59 Latin America Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 60 Brazil Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 61 Argentina Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 62 Rest of Latin America Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 63 Middle East Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 64 UAE Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 65 Saudi Arabia Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 66 Rest of Middle East Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 67 Africa Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 68 South Africa Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 69 Egypt Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)
FIG. 70 Rest of Africa Thyroid Gland Disorders Treatment Market, 2019-2032 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Thyroid Gland Disorders Treatment Market
TABLE 2 Global Thyroid Gland Disorders Treatment Market: Drivers Impact Analysis
TABLE 3 Global Thyroid Gland Disorders Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Thyroid Gland Disorders Treatment Market, by Competitive Benchmarking, 2023
TABLE 5 Global Thyroid Gland Disorders Treatment Market, by Geographical Presence Analysis, 2023
TABLE 6 Global Thyroid Gland Disorders Treatment Market, by Key Strategies Analysis, 2023
TABLE 7 Global Thyroid Gland Disorders Treatment Market, by Hypothyroidism, By Region, 2019-2023 (US$ Mn)
TABLE 8 Global Thyroid Gland Disorders Treatment Market, by Hypothyroidism, By Region, 2023-2032 (US$ Mn)
TABLE 9 Global Thyroid Gland Disorders Treatment Market, by Hyperthyroidism, By Region, 2019-2023 (US$ Mn)
TABLE 10 Global Thyroid Gland Disorders Treatment Market, by Hyperthyroidism, By Region, 2023-2032 (US$ Mn)
TABLE 11 Global Thyroid Gland Disorders Treatment Market, by Thyroid Nodules, By Region, 2019-2023 (US$ Mn)
TABLE 12 Global Thyroid Gland Disorders Treatment Market, by Thyroid Nodules, By Region, 2023-2032 (US$ Mn)
TABLE 13 Global Thyroid Gland Disorders Treatment Market, by Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis), By Region, 2019-2023 (US$ Mn)
TABLE 14 Global Thyroid Gland Disorders Treatment Market, by Thyroiditis (e.g., Hashimoto’s thyroiditis, postpartum thyroiditis), By Region, 2023-2032 (US$ Mn)
TABLE 15 Global Thyroid Gland Disorders Treatment Market, by Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma), By Region, 2019-2023 (US$ Mn)
TABLE 16 Global Thyroid Gland Disorders Treatment Market, by Thyroid Cancer (e.g., papillary carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma), By Region, 2023-2032 (US$ Mn)
TABLE 17 Global Thyroid Gland Disorders Treatment Market, by Medications, By Region, 2019-2023 (US$ Mn)
TABLE 18 Global Thyroid Gland Disorders Treatment Market, by Medications, By Region, 2023-2032 (US$ Mn)
TABLE 19 Global Thyroid Gland Disorders Treatment Market, by Surgical Interventions, By Region, 2019-2023 (US$ Mn)
TABLE 20 Global Thyroid Gland Disorders Treatment Market, by Surgical Interventions, By Region, 2023-2032 (US$ Mn)
TABLE 21 Global Thyroid Gland Disorders Treatment Market, by Thyroid Function Tests (e.g., TSH, T3, T4 levels), By Region, 2019-2023 (US$ Mn)
TABLE 22 Global Thyroid Gland Disorders Treatment Market, by Thyroid Function Tests (e.g., TSH, T3, T4 levels), By Region, 2023-2032 (US$ Mn)
TABLE 23 Global Thyroid Gland Disorders Treatment Market, by Thyroid Ultrasound, By Region, 2019-2023 (US$ Mn)
TABLE 24 Global Thyroid Gland Disorders Treatment Market, by Thyroid Ultrasound, By Region, 2023-2032 (US$ Mn)
TABLE 25 Global Thyroid Gland Disorders Treatment Market, by Fine Needle Aspiration Biopsy (FNAB), By Region, 2019-2023 (US$ Mn)
TABLE 26 Global Thyroid Gland Disorders Treatment Market, by Fine Needle Aspiration Biopsy (FNAB), By Region, 2023-2032 (US$ Mn)
TABLE 27 Global Thyroid Gland Disorders Treatment Market, by Thyroid Scan (e.g., radioactive iodine scan), By Region, 2019-2023 (US$ Mn)
TABLE 28 Global Thyroid Gland Disorders Treatment Market, by Thyroid Scan (e.g., radioactive iodine scan), By Region, 2023-2032 (US$ Mn)
TABLE 29 Global Thyroid Gland Disorders Treatment Market, by Molecular Testing (e.g., genetic testing for thyroid cancer), By Region, 2019-2023 (US$ Mn)
TABLE 30 Global Thyroid Gland Disorders Treatment Market, by Molecular Testing (e.g., genetic testing for thyroid cancer), By Region, 2023-2032 (US$ Mn)
TABLE 31 Global Thyroid Gland Disorders Treatment Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 32 Global Thyroid Gland Disorders Treatment Market, by Others, By Region, 2023-2032 (US$ Mn)
TABLE 33 Global Thyroid Gland Disorders Treatment Market, by Hospitals, By Region, 2019-2023 (US$ Mn)
TABLE 34 Global Thyroid Gland Disorders Treatment Market, by Hospitals, By Region, 2023-2032 (US$ Mn)
TABLE 35 Global Thyroid Gland Disorders Treatment Market, by Specialty Clinics, By Region, 2019-2023 (US$ Mn)
TABLE 36 Global Thyroid Gland Disorders Treatment Market, by Specialty Clinics, By Region, 2023-2032 (US$ Mn)
TABLE 37 Global Thyroid Gland Disorders Treatment Market, by Diagnostic Laboratories, By Region, 2019-2023 (US$ Mn)
TABLE 38 Global Thyroid Gland Disorders Treatment Market, by Diagnostic Laboratories, By Region, 2023-2032 (US$ Mn)
TABLE 39 Global Thyroid Gland Disorders Treatment Market, by Ambulatory Surgical Centers, By Region, 2019-2023 (US$ Mn)
TABLE 40 Global Thyroid Gland Disorders Treatment Market, by Ambulatory Surgical Centers, By Region, 2023-2032 (US$ Mn)
TABLE 41 Global Thyroid Gland Disorders Treatment Market, by Cancer Treatment Centers, By Region, 2019-2023 (US$ Mn)
TABLE 42 Global Thyroid Gland Disorders Treatment Market, by Cancer Treatment Centers, By Region, 2023-2032 (US$ Mn)
TABLE 43 Global Thyroid Gland Disorders Treatment Market, by Others, By Region, 2019-2023 (US$ Mn)
TABLE 44 Global Thyroid Gland Disorders Treatment Market, by Others, By Region, 2023-2032 (US$ Mn)
TABLE 45 Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 46 Global Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 47 Global Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 48 Global Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 49 Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 50 Global Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 51 Global Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 52 Global Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 53 Global Thyroid Gland Disorders Treatment Market, by Region, 2019-2023 (US$ Mn)
TABLE 54 Global Thyroid Gland Disorders Treatment Market, by Region, 2023-2032 (US$ Mn)
TABLE 55 North America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 56 North America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 57 North America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 58 North America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 59 North America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 60 North America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 61 North America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 62 North America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 63 North America Thyroid Gland Disorders Treatment Market, by Country, 2019-2023 (US$ Mn)
TABLE 64 North America Thyroid Gland Disorders Treatment Market, by Country, 2023-2032 (US$ Mn)
TABLE 65 United States Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 66 United States Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 67 United States Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 68 United States Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 69 United States Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 70 United States Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 71 United States Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 72 United States Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 73 Canada Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 74 Canada Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 75 Canada Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 76 Canada Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 77 Canada Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 78 Canada Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 79 Canada Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 80 Canada Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 81 Mexico Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 82 Mexico Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 83 Mexico Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 84 Mexico Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 85 Mexico Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 86 Mexico Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 87 Mexico Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 88 Mexico Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 89 Europe Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 90 Europe Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 91 Europe Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 92 Europe Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 93 Europe Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 94 Europe Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 95 Europe Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 96 Europe Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 97 Europe Thyroid Gland Disorders Treatment Market, by Country, 2019-2023 (US$ Mn)
TABLE 98 Europe Thyroid Gland Disorders Treatment Market, by Country, 2023-2032 (US$ Mn)
TABLE 99 Germany Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 100 Germany Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 101 Germany Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 102 Germany Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 103 Germany Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 104 Germany Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 105 Germany Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 106 Germany Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 107 France Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 108 France Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 109 France Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 110 France Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 111 France Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 112 France Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 113 France Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 114 France Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 115 United Kingdom Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 116 United Kingdom Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 117 United Kingdom Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 118 United Kingdom Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 119 United Kingdom Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 120 United Kingdom Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 121 United Kingdom Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 122 United Kingdom Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 123 Italy Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 124 Italy Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 125 Italy Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 126 Italy Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 127 Italy Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 128 Italy Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 129 Italy Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 130 Italy Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 131 Spain Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 132 Spain Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 133 Spain Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 134 Spain Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 135 Spain Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 136 Spain Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 137 Spain Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 138 Spain Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 139 Benelux Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 140 Benelux Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 141 Benelux Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 142 Benelux Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 143 Benelux Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 144 Benelux Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 145 Benelux Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 146 Benelux Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 147 Russia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 148 Russia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 149 Russia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 150 Russia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 151 Russia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 152 Russia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 153 Russia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 154 Russia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 155 Rest of Europe Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 156 Rest of Europe Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 157 Rest of Europe Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 158 Rest of Europe Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 159 Rest of Europe Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 160 Rest of Europe Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 161 Rest of Europe Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 162 Rest of Europe Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 163 Asia Pacific Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 164 Asia Pacific Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 165 Asia Pacific Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 166 Asia Pacific Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 167 Asia Pacific Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 168 Asia Pacific Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 169 Asia Pacific Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 170 Asia Pacific Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 171 China Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 172 China Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 173 China Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 174 China Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 175 China Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 176 China Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 177 China Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 178 China Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 179 Japan Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 180 Japan Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 181 Japan Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 182 Japan Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 183 Japan Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 184 Japan Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 185 Japan Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 186 Japan Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 187 India Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 188 India Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 189 India Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 190 India Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 191 India Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 192 India Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 193 India Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 194 India Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 195 South Korea Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 196 South Korea Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 197 South Korea Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 198 South Korea Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 199 South Korea Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 200 South Korea Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 201 South Korea Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 202 South Korea Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 203 South-East Asia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 204 South-East Asia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 205 South-East Asia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 206 South-East Asia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 207 South-East Asia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 208 South-East Asia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 209 South-East Asia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 210 South-East Asia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 211 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 212 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 213 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 214 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 215 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 216 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 217 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 218 Rest of Asia Pacific Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 219 Latin America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 220 Latin America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 221 Latin America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 222 Latin America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 223 Latin America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 224 Latin America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 225 Latin America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 226 Latin America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 227 Brazil Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 228 Brazil Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 229 Brazil Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 230 Brazil Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 231 Brazil Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 232 Brazil Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 233 Brazil Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 234 Brazil Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 235 Argentina Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 236 Argentina Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 237 Argentina Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 238 Argentina Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 239 Argentina Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 240 Argentina Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 241 Argentina Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 242 Argentina Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 243 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 244 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 245 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 246 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 247 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 248 Rest of Latin America Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 249 Rest of Latin America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 250 Rest of Latin America Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 251 Middle East Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 252 Middle East Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 253 Middle East Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 254 Middle East Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 255 Middle East Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 256 Middle East Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 257 Middle East Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 258 Middle East Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 259 UAE Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 260 UAE Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 261 UAE Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 262 UAE Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 263 UAE Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 264 UAE Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 265 UAE Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 266 UAE Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 267 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 268 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 269 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 270 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 271 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 272 Saudi Arabia Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 273 Saudi Arabia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 274 Saudi Arabia Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 275 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 276 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 277 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 278 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 279 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 280 Rest of Middle East Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 281 Rest of Middle East Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 282 Rest of Middle East Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 283 Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 284 Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 285 Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 286 Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 287 Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 288 Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 289 Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 290 Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 291 South Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 292 South Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 293 South Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 294 South Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 295 South Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 296 South Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 297 South Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 298 South Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 299 Egypt Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 300 Egypt Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 301 Egypt Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 302 Egypt Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 303 Egypt Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 304 Egypt Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 305 Egypt Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 306 Egypt Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)
TABLE 307 Rest of Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2019-2023 (US$ Mn)
TABLE 308 Rest of Africa Thyroid Gland Disorders Treatment Market, By Type of Thyroid Disorder, 2023-2032 (US$ Mn)
TABLE 309 Rest of Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2019-2023 (US$ Mn)
TABLE 310 Rest of Africa Thyroid Gland Disorders Treatment Market, By Treatment Modality, 2023-2032 (US$ Mn)
TABLE 311 Rest of Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2019-2023 (US$ Mn)
TABLE 312 Rest of Africa Thyroid Gland Disorders Treatment Market, By Diagnostic Tests, 2023-2032 (US$ Mn)
TABLE 313 Rest of Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2019-2023 (US$ Mn)
TABLE 314 Rest of Africa Thyroid Gland Disorders Treatment Market, By End-User, By Region, 2023-2032 (US$ Mn)

Frequently Asked Questions:

What is the current size of the global Thyroid Gland Disorders Treatment Market?

The global Thyroid Gland Disorders Treatment Market was valued at USD 2451.2 Million in 2023.

What is the expected growth rate of the Thyroid Gland Disorders Treatment Market between 2024 and 2032?

The Thyroid Gland Disorders Treatment Market is expected to grow at a CAGR of 3.50% between 2024 and 2032, reaching USD 3340.7 million in 2032.

Which segment is leading the market share in terms of Treatment Modality?

In 2023, medications will dominate the global market for thyroid gland disorders.

Which End-User segment governs the demand for Therapeutic Monoclonal Antibodies in the world?

Hospitals account for the majority of the thyroid gland disease treatment market.

Who are the major players in the global Thyroid Gland Disorders Treatment Market?

The top players include Abbvie Inc., Amgen Inc., GSK Plc, Merck KGaA and Others.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –